Baskent University Hospital
Ankara, 06790, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT07659925
This randomized controlled study aims to compare the effects of different periodization-based strength training approaches in individuals with type 2 diabetes mellitus. Participants will be allocated to non-linear periodization, linear periodization, or control groups. The intervention program will be conducted for 8 weeks and will evaluate exercise capacity, muscle strength, quality of life, body composition, and metabolic parameters.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
Ankara, 06790, Turkey (Türkiye)
Location status: Recruiting
Type 2 diabetes mellitus is associated with reduced exercise capacity, decreased muscle strength, impaired quality of life, and metabolic dysfunction. Exercise training is recommended as an important component of diabetes management; however, the comparative effectiveness of different strength training periodization approaches remains unclear.
This randomized controlled trial aims to compare the effects of non-linear periodization and linear periodization strength training programs in individuals with type 2 diabetes mellitus. Participants will be randomized into three groups: a non-linear periodization training group, a linear periodization training group, and a control group receiving usual care.
The intervention will be conducted for 8 weeks, three times per week. Outcomes including exercise capacity, muscle strength, body composition, quality of life, and metabolic parameters will be evaluated before and after the intervention period.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will perform supervised non-linear periodization-based strength training three times per week for 8 weeks.
Participants will perform supervised linear periodization-based strength training three times per week for 8 weeks.
Participants will receive usual care and no structured exercise intervention during the study period.
Time frame: Baseline and after 8 week
Exercise capacity will be assessed using the 6-Minute Walk Test (6MWT)
Time frame: Baseline and after 8 weeks
Peripheral muscle strength will be assessed using handheld dynamometry for upper and lower extremity muscle groups and reported in Newton (N).
Time frame: Baseline and after 8 weeks
Hand grip strength will be assessed using a hand dynamometer and reported in kilograms (kg).
Time frame: Baseline and after 8 weeks
Change in the Turkish version of the Diabetes Quality of Life Questionnaire (DQOL) total score and subscale scores from baseline to 8 weeks will be evaluated. The DQOL consists of 45 items assessing treatment satisfaction, psychological impact, concerns about future effects of diabetes, and social/vocational concerns. Each item is scored on a 1-5 scale, and higher scores indicate better diabetes-related quality of life.
Time frame: Baseline and after 8 weeks
Body fat percentage (%) will be assessed using bioelectrical impedance analysis (BIA).
Time frame: Baseline and after 8 weeks
Skeletal muscle mass (kg) will be assessed using bioelectrical impedance analysis (BIA).
Time frame: Baseline and after 8 weeks
Resting metabolic rate (kcal/day) will be assessed using indirect calorimetry (COSMED Fitmate Pro, Rome, Italy).
Time frame: Baseline and after 8 weeks
Glycemic control will be assessed by measuring glycated hemoglobin (HbA1c) levels (%).
Time frame: Baseline and after 8 weeks
Glycemic control will be assessed by measuring fasting blood glucose levels (mg/dL).
Contact information is provided by the study sponsor or research team.
Baskent University
Other
A Comparison of the Effects of Different Periodization-Based Strength Training Programs in Individuals With Type 2 Diabetes Mellitus
Acronym: T2DM_NLP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07032844
Diabetes Mellitus, Diabetes Mellitus, Type 2
Birmingham, Alabama, United States
View Trial DetailsNCT06067399
Diabetes Mellitus, Diabetes Mellitus, Type 2
Al Khārjah, Egypt
View Trial DetailsNCT07564414
Body Weight, Diabetes Mellitus
Birmingham, Alabama, United States
View Trial DetailsNCT07622628
Diabetes Mellitus, Diabetes Mellitus Type 2
Izmir, Turkey (Türkiye)
View Trial Details